名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
Orchestra BioMed Holdings Inc | OBIO | NASDAQ | 普通株式 |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
6.80 | 6.63 | 7.00 | 6.85 | 6.89 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/6/11 | 21:01 | EDGAR2 | Form 8-K - Current report |
2024/6/04 | 05:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/5/28 | 13:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
2024/5/25 | 05:16 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2024/5/14 | 05:38 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2024/5/11 | 06:25 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/5/11 | 06:24 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/5/11 | 06:23 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/5/11 | 06:18 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/5/10 | 06:04 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2023/9/19 | 23:19 | DJN | Orchestra BioMed Shares Jump on FDA Nod for BackBeat Study |
2023/9/19 | 21:24 | DJN | Orchestra BioMed Gets FDA Nod for BackBeat Study |